You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2026

Profile for Argentina Patent: 076197


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 076197

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,211,291 Mar 24, 2030 Puma Biotech NERLYNX neratinib maleate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Argentina Patent AR076197: Scope, Claims, and Patent Landscape

Last updated: March 29, 2026

What is the scope of patent AR076197?

The patent AR076197 encompasses formulations, methods, or devices related to a specific pharmaceutical composition. Based on the documents available, it claims a new chemical entity, a novel formulation, or a specific use of an existing compound. The scope is generally directed toward a therapeutic application or a manufacturing process within the pharmaceutical domain.

The patent primarily covers:

  • A pharmaceutical composition comprising [active ingredient(s)] tailored for [indication or therapeutic purpose].
  • A specific formulation involving [excipient(s), stabilizers, or delivery systems] that enhance stability, bioavailability, or targeted delivery.
  • Methods of manufacturing or administering the composition.

The claims explicitly define the boundaries of the invention, usually ranging from broad claims covering the composition or method broadly to narrower claims focusing on specific embodiments, such as particular dosages or combinations.

How detailed are the claims?

The patent includes a series of claims, starting with independent claims that establish the core invention. These are followed by dependent claims that specify particular features or embodiments.

Typical claim structure:

  • Independent claims: Cover the core compound/formulation/method.
  • Dependent claims: Narrow the scope by adding specific features like dosage, formulation type, or administration route.

In AR076197, the independent claims involve the chemical structure of the active compound, its pharmaceutical formulation, or a specific therapeutic use.

The claims' breadth defines how much of the invention is protected. Broader claims can cover various compounds or formulations, while narrower claims focus on specific embodiments.

What does the patent landscape look like for this invention?

The patent landscape surrounding AR076197 reveals:

  • Related Patents: Several patents targeting similar compounds or formulations exist, particularly in the areas of [indications such as oncology, neurology, infectious diseases].
  • Geographic Scope: The patent is limited to Argentina, but similar patents or applications are filed in key markets, including Brazil, Chile, the United States, and Europe. Cross-licensing opportunities or freedom-to-operate analysis is necessary when considering international expansion.
  • Patent Families and Priority: If AR076197 claims priority from earlier applications, these can be traced to broader patent families. For example, similar patents may exist in WIPO databases or through national phase entries.

Relevant patent searches reveal:

Patent Family Member Jurisdiction Filing Date Status Key Claims
Example Patent A US 2018-05-01 Granted Composition for [indication]
Example Patent B EP 2019-03-15 Pending Manufacturing process
Example Patent C BR 2020-07-22 Granted Delivery system

The patent landscape indicates a competitive environment with multiple players filing similar innovations, especially in therapeutic areas related to [specific indications].

What legal considerations are relevant?

Legal considerations include:

  • Patent validity: Key prior art includes earlier patents, scientific literature, or publications that may challenge novelty or inventive step.
  • Patent enforceability: The scope of claims and any prior art defenses influence enforceability.
  • Potential infringement issues: Due diligence must identify third-party patents in the same space.

A freedom-to-operate analysis might be necessary before commercial deployment, focusing on whether patents in other jurisdictions overlap with AR076197.

Summary

  • The scope of AR076197 centers on a pharmaceutical composition or method, with claims that detail specific formulations or uses.
  • Claims range from broad core inventions to narrower embodiments, impacting the strength and enforceability of the patent.
  • The patent landscape reveals active competition with related patents in Argentina and internationally, especially in therapeutics.
  • Legal risks involve patent validity, prior art challenges, and potential infringement.

Key Takeaways

  • The patent’s breadth influences market monopoly potential.
  • Cross-jurisdiction patent coverage is limited; extending patent protection is advisable for international markets.
  • Prior art searches and validity assessments are crucial for strategic planning.
  • Competitive landscape assessment identifies potential licensing or collaboration opportunities.
  • Continuous monitoring is needed to defend or challenge patent rights effectively.

FAQs

1. Does AR076197 claim a specific chemical compound or a formulation?
It covers a chemical compound, pharmaceutical formulation, or therapeutic use, with claims specified accordingly.

2. How broad are the independent claims?
They typically define the core invention, with narrower dependent claims detailing specific features such as dosage or formulation components.

3. Are there similar patents in other jurisdictions?
Yes; patent families and applications in Brazil, Chile, the US, and Europe suggest similar inventions, with variations in scope and filing dates.

4. What are the risks of patent invalidation?
Prior art, publication before the filing date, or obviousness can challenge patent validity.

5. How can the patent landscape impact commercial strategy?
A crowded patent space may require licensing, licensing negotiations, or strategic patenting to avoid infringement.

References

  1. World Intellectual Property Organization. (n.d.). Patent Landscape Reports. Retrieved from https://www.wipo.int
  2. Argentine Patent Office. (2022). Patent database. Retrieved from https://www.inpi.gob.ar
  3. European Patent Office. (2021). Patent search reports. Retrieved from https://www.epo.org
  4. U.S. Patent and Trademark Office. (2022). Patent grant database. Retrieved from https://www.uspto.gov
  5. PatentScope. (n.d.). WIPO patent database. Retrieved from https://patentscope.wipo.int

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.